Private Equity
Thoma Bravo supports San Francisco children and their families during the COVID-19 crisis and Catalyst Capital anticipates an economic slowdown lasting for a long time.
3 min read · 31 March 2020
LPs default during the COVID-19 crisis and Ares is putting Unified Women's Healthcare on the block.
3 min read · 30 March 2020
Despite the coronavirus crisis, business still goes on at some PE firms: Hillhouse is seeking to raise up to $13 billion for its next fund while HGGC is scouring for new M&A ventures.
4 min read · 27 March 2020
PE firms move slowly into offense mode amid the coronavirus crisis and Thoma Bravo shelves its sale of Imprivata.
4 min read · 26 March 2020
Despite the current coronavirus crisis, deals are being prepped.
3 min read · 26 March 2020
Thomas Friedman recently argued that “the coronavirus will create a new historical divide: before-Corona (BC) and after-Corona (AC).”
3 min read · 25 March 2020
COVID-19 crisis could bode well for new M&A tech opportunities and Gryphon launches sixth fund.
3 min read · 25 March 2020
Amid the COVID-9 crisis, some firms are invoking the MAC clause to pull out of deals.
3 min read · 24 March 2020
Thoma Bravo calls off its potential $2 billion-plus sale of Imprivata amid the coronavirus pandemic and New York State Common Retirement Fund commits to a $2 billion co-investment fund with Neuberger Berman.
3 min read · 23 March 2020
MiddleGround is paying leave for employees who test positive for COVID-19 and trying to de-stress during a period of excessive stress.
4 min read · 20 March 2020
